These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33713279)

  • 1. Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions.
    van Ophoven A; Engelberg S; Lilley H; Sievert KD
    Adv Ther; 2021 Apr; 38(4):1987-2006. PubMed ID: 33713279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis.
    Kessler TM; La Framboise D; Trelle S; Fowler CJ; Kiss G; Pannek J; Schurch B; Sievert KD; Engeler DS
    Eur Urol; 2010 Dec; 58(6):865-74. PubMed ID: 20934242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacral Neuromodulation in Patients With Neurogenic Lower Urinary Tract Dysfunction: A Multicenter Retrospective Study From China.
    Masood I; Chen Q; Li J; Xu Z; Ying X; Wang Y; Chen G; Liao L
    Neuromodulation; 2021 Oct; 24(7):1278-1283. PubMed ID: 33908130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of sacral neuromodulation in male patients with overactive bladder, chronic pelvic pain, and fecal incontinence.
    Ferreira R; Alwashmi E; Otis-Chapados S; Bhojani N; Zorn KC; Chughtai B; Elterman DS
    Can J Urol; 2024 Aug; 31(4):11943-11949. PubMed ID: 39217518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction.
    Wöllner J; Krebs J; Pannek J
    Spinal Cord; 2016 Feb; 54(2):137-40. PubMed ID: 26215913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral neuromodulation: No more skiing?
    Wöllner J; Pannek J
    Scand J Urol; 2016; 50(2):132-3. PubMed ID: 26754577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects.
    Tilborghs S; De Wachter S
    Expert Rev Med Devices; 2022 Feb; 19(2):161-187. PubMed ID: 35061951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
    Chen G; Liao L; Wang Y; Ying X
    Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Invasive neurostimulation in neuro-urology: state of the art].
    Kurze I; Böthig R; van Ophoven A
    Aktuelle Urol; 2024 Aug; 55(4):351-364. PubMed ID: 38631373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neuromodulation in patients with neurogenic overactive bladder.
    Lay AH; Das AK
    Curr Urol Rep; 2012 Oct; 13(5):343-7. PubMed ID: 22865208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction?
    Averbeck MA; Moreno-Palacios J; Aparicio A
    Int Braz J Urol; 2020; 46(6):891-901. PubMed ID: 32758301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial Comment: Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dys-function (nLUTD): Over 20 Years' Experience and Fu-ture Directions.
    Averbeck MA
    Int Braz J Urol; 2021; 47(6):1264-1265. PubMed ID: 34469676
    [No Abstract]   [Full Text] [Related]  

  • 13. Sacral Neuromodulation for Lower Urinary Tract Dysfunction in Spinal Cord Injury: A Systematic Review and Meta-Analysis.
    Hu M; Lai S; Zhang Y; Liu M; Wang J
    Urol Int; 2019; 103(3):337-343. PubMed ID: 31362290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary analysis of stimulation parameters for sacral neuromodulation in different indications: a multicenter retrospective cohort study from China.
    Meng L; Yan Z; Wang X; Zhang Y; Zhu Z; Zhu W; Ling Q; Sun X; Gu Y; Lv J; Li Y
    Int J Surg; 2024 Jun; 110(6):3536-3542. PubMed ID: 38445489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction.
    Liechti MD; van der Lely S; Knüpfer SC; Abt D; Kiss B; Leitner L; Mordasini L; Tornic J; Wöllner J; Mehnert U; Bachmann LM; Burkhard FC; Engeler DS; Pannek J; Kessler TM
    NEJM Evid; 2022 Nov; 1(11):EVIDoa2200071. PubMed ID: 38319849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis.
    Yang G; Xu Y; Qu G; Zhang Y
    PLoS One; 2020; 15(3):e0230355. PubMed ID: 32226049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral neuromodulation for low anterior resection syndrome: current status-a systematic review and meta-analysis.
    Pires M; Severo M; Lopes A; Neves S; Matzel K; Povo A
    Int J Colorectal Dis; 2023 Jul; 38(1):189. PubMed ID: 37428256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment.
    Marcelissen TA; Leong RK; Nieman FH; van Lankveld JJ; van Kerrebroeck PE; de Wachter SG
    BJU Int; 2011 Dec; 108(11):1834-8. PubMed ID: 21810157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
    Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
    World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.